Journal
TRANSPLANTATION PROCEEDINGS
Volume 48, Issue 8, Pages 2756-2762Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.transproceed.2016.06.047
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81273256, 81571561]
Ask authors/readers for more resources
Background. Calcineurin inhibitor-associated chronic nephrotoxicity threatens the prognosis of liver transplant recipients. This study aimed to study the mechanisms involved by identifying the cytokine profiles in tacrolimus (Tac)-induced nephrotoxicity. Methods. We enrolled 125 living-donor liver transplant recipients. All of the recipients had normal serum cystatin (Cys) C and urine microalbumin before transplantation. They received a Tac-based immunosuppressive regimen (Tac + mycophenolate mofetil + prednisone) thereafter. Patients were grouped according to Cys-C results (measured a mean 3.55 +/- 1.89 years after transplantation) as a measure of renal injury: the early renal damage group was Cys-C >1 mg/L, and normal renal function was Cys-C <= 1 mg/L. Serum levels of 10 cytokines and chemokines, as well as urine proteins including alpha 1 microglobulin, microalbumin, transferrin, and immunoglobulin G, were compared between groups. Results. In the early renal damage group, the concentration of interferon-gamma-induced protein (IP) 10 was higher and monocyte chemotactic protein (MCP) 1 was lower compared with the group with normal renal function (P = .027 and .048, respectively). Multivariate logarithmic regression analysis showed that IP-10 and MCP-1 were independently correlated with renal damage. Conclusions. High level of IP-10 and low level of MCP-1 may be involved in renal injury and therefore may indicate poor prognosis. IP-10 could be a target for renal injury treatment after liver transplantation. Further studies with larger sample sizes are recommended to validate the study results.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available